Veldic M, Caruncho H J, Liu W S, Davis J, Satta R, Grayson D R, Guidotti A, Costa E
Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, USA.
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):348-53. doi: 10.1073/pnas.2637013100. Epub 2003 Dec 18.
A down-regulation of reelin and glutamic acid decarboxylase (GAD) 67 mRNAs was detected in gamma-aminobutyric acid (GABA)ergic cortical interneurons of schizophrenia (SZ) postmortem brains (10), suggesting that the availability of GABA and reelin may be decreased in SZ cortex. In situ hybridization of the mRNA encoding for DNA-methyltransferase 1, which catalyzes the methylation of promoter CpG islands, shows that the expression of this mRNA is increased in cortical GABAergic interneurons but not in pyramidal neurons of SZ brains. Counts of reelin mRNA-positive neurons in Brodmann's area 10 of either nonpsychiatric subjects or SZ patients show that the expression of reelin mRNA is decreased in layer-I, -II, and -IV GABAergic interneurons of SZ patients. These findings are consistent with the hypothesis that the increase of DNA-methyltransferase 1 expression in telencephalic GABAergic interneurons of SZ patients causes a promoter hypermethylation of reelin and GAD(67) and perhaps of other genes expressed in these interneurons. It is difficult to decide whether this dysfunction of GABAergic neurons detected in SZ is responsible for this disease or is a consequence of this disorder. Although at present we cannot differentiate between these two alternatives, it is important to consider that so far a molecular pathology of cortical GABAergic neurons appears to be the most consistent finding associated with SZ morbidity.
在精神分裂症(SZ)患者死后大脑的γ-氨基丁酸(GABA)能皮质中间神经元中,检测到Reelin和谷氨酸脱羧酶(GAD)67 mRNA的下调(10),这表明SZ皮质中GABA和Reelin的可用性可能降低。催化启动子CpG岛甲基化的DNA甲基转移酶1编码mRNA的原位杂交显示,该mRNA的表达在皮质GABA能中间神经元中增加,但在SZ大脑的锥体神经元中未增加。对非精神科受试者或SZ患者的布罗德曼10区中Reelin mRNA阳性神经元的计数显示,SZ患者的I、II和IV层GABA能中间神经元中Reelin mRNA的表达降低。这些发现与以下假设一致:SZ患者端脑GABA能中间神经元中DNA甲基转移酶1表达的增加导致Reelin和GAD(67)以及这些中间神经元中可能表达的其他基因的启动子高甲基化。很难确定在SZ中检测到的GABA能神经元功能障碍是该疾病的原因还是该疾病的结果。虽然目前我们无法区分这两种情况,但重要的是要考虑到,到目前为止,皮质GABA能神经元的分子病理学似乎是与SZ发病相关的最一致的发现。